← Back to the fund page Use your browser's print dialog and choose “Save as PDF”. A4.
MF Analyser

Mahindra Manulife Multi Cap Fund

Regular Plan · Growth · Multi Cap · Scheme code 141224

NAV₹39.8626as on 11 Nov 2026
Fund houseMahindra Manulife Mutual Fund
CategoryMulti Cap
Plan & optionRegular · Growth
History9.5 years

Returns (%)

 1M3M6M1Y3Y5Y7Y10YLaunch
This scheme 5.660.9110.51 10.3816.4113.13 19.47—15.69
NIFTY 500 Multicap 50:25:25 TRI
benchmark		 -6.01-5.078.14 -1.4910.5710.78 17.0213.7115.91
Multi Cap
category median		 ——— 5.0314.2211.59 —14.08—

Over a year annualised (CAGR), under a year absolute. Computed from AMFI's published NAV history for this scheme.

Risk

 VolatilitySharpeSortinoBetaAlphaMax fallR²
This scheme 16.9% 0.59 0.89 0.98 2.69% -34.5% 92.28
NIFTY 500 Multicap 50:25:25 TRI
benchmark		 16.7%0.24 0.37—— -41.7%—

Risk-free rate 6.5%. Beta, alpha and R² are regressed on the 36 months this scheme and its benchmark share.

Growth of ₹100 since launch

5918230442720182020202220242026MF Analyser

Drawdown from peak (%)

0%-11%-22%-34%20182020202220242026

Every one-year period it has lived through

WindowsWorstMedianBestPeriods that lost money
2,090 -25.8% 9.1% 95.7% 20%

Every one-year holding period in this scheme's history, not just the last one — the spread a real investor would have met depending only on when they started.

How it behaves against its benchmark

Up captureDown captureCorrelation Tracking errorInformation ratioTreynor
109% 100% 0.96 4.7% 0.59 8.11

Up capture is how much of the benchmark's gain this scheme kept in the months the benchmark rose; down capture, how much of its fall it took. Below 100 on the down side and above it on the up side is the combination every fund is trying for and few reach. Measured over the 36 months this scheme and NIFTY 500 Multicap 50:25:25 TRI share.

MF Analyser

Mahindra Manulife Multi Cap Fund

Regular Plan · Growth

Allocation

By asset

Equity92.81%
Cash & Equivalents7.27%
Mutual Fund Units0.67%

By market cap

Large Cap38.49%
Mid Cap30.11%
Small Cap24.21%
Unclassified0.67%

Concentration

Number of stocks74
Top 5 stocks18.12%
Top 10 stocks29.98%
Top 20 stocks47.75%
Lines in the filing78
Largest holding5.01%
Largest sectorPharmaceuticals & Biotechnology 16.15%
Effective stocks57.2
Sectors held32
Cash7.27%

Effective stocks is what the concentration works out to: a fund holding 74 names but most of its money in a few behaves like a fund of 57. Cash includes repo and TREPS, which every fund parks money in overnight.

Sector split

Pharmaceuticals & Biotechnology — 16.2%Banks — 12.6%Industrial Products — 8.6%Cash & Equivalents — 7.3%Capital Markets — 6.1%Retailing — 4.4%IT - Software — 3.8%Cement & Cement Products — 3.5%Consumer Durables — 3.3%Other — 35.0%Pharmaceuticals & Biotech…16.2%Banks12.6%Industrial Products8.6%Cash & Equivalents7.3%Capital Markets6.1%Retailing4.4%IT - Software3.8%Cement & Cement Products3.5%Consumer Durables3.3%Other35.0%
Pharmaceuticals & Biotechnology16.15%
Banks12.64%
Industrial Products8.62%
Cash & Equivalents7.27%
Capital Markets6.12%
Retailing4.38%
IT - Software3.75%
Cement & Cement Products3.46%
Consumer Durables3.32%
Non - Ferrous Metals2.94%
Oil2.83%
Metals & Minerals Trading2.79%
Automobiles2.60%
Power2.35%
Finance2.04%
Beverages2.03%
Financial Technology (Fintech)1.90%
Electrical Equipment1.90%
Chemicals & Petrochemicals1.87%
Entertainment1.52%
MF Analyser

Mahindra Manulife Multi Cap Fund

Regular Plan · Growth · holdings as on 30 Sep 2026

Top 30 holdings

#CompanySectorShares held Value
₹ cr		% of fund
1 Triparty Repo Unclassified — 435 5.83%
2 Divi's Laboratories Limited Pharmaceuticals & Biotechnology 402,300 374 5.01%
3 Multi Commodity Exchange of India Limited Capital Markets 951,000 314 4.21%
4 ICICI Bank Limited Banks 1,837,000 243 3.26%
5 HDFC Bank Limited Banks 3,000,000 213 2.85%
6 Adani Enterprises Limited Metals & Minerals Trading 716,380 208 2.79%
7 Neuland Laboratories Limited Pharmaceuticals & Biotechnology 95,343 204 2.73%
8 Oil India Limited Oil 4,100,330 184 2.47%
9 Torrent Pharmaceuticals Limited Pharmaceuticals & Biotechnology 365,053 175 2.35%
10 APL Apollo Tubes Limited Industrial Products 736,349 161 2.16%
11 PTC Industries Ltd Industrial Products 72,195 160 2.15%
12 Avenue Supermarts Limited Retailing 396,000 151 2.02%
13 Hindustan Zinc Limited Non - Ferrous Metals 2,550,000 144 1.94%
14 Voltamp Transformers Limited Electrical Equipment 135,225 142 1.90%
15 Jindal Saw Ltd Industrial Products 5,025,709 140 1.87%
16 UltraTech Cement Limited Cement & Cement Products 125,000 137 1.84%
17 State Bank of India Banks 1,390,000 133 1.79%
18 Oracle Financial Services Software Limited IT - Software 120,000 128 1.71%
19 P N Gadgil Jewellers Limited Consumer Durables 2,000,475 118 1.58%
20 Adani Energy Solutions Limited Power 888,000 117 1.57%
21 Alkem Laboratories Limited Pharmaceuticals & Biotechnology 223,414 115 1.55%
22 Sun TV Network Limited Entertainment 1,872,892 113 1.52%
23 Bajaj Auto Limited Automobiles 97,975 107 1.43%
24 Bandhan Bank Limited Banks 5,922,142 106 1.42%
25 Aarti Industries Limited Chemicals & Petrochemicals 2,160,917 103 1.38%
26 Vodafone Idea Limited Telecom - Services 76,500,000 99 1.33%
27 Supreme Industries Limited Industrial Products 279,853 97 1.30%
28 Manappuram Finance Limited Finance 3,028,269 96 1.28%
29 Radico Khaitan Limited Beverages 213,327 93 1.25%
30 MphasiS Limited IT - Software 423,275 91 1.22%
MF Analyser

Mahindra Manulife Multi Cap Fund

Regular Plan · Growth · where the money sits

What the manager did last month

Between the filings of 31 Aug 2026 and 30 Sep 2026. A position grows because the manager bought or because the price rose; only the share count separates them.

BoughtSoldNew positionsSold out ofPrice move of holdings
₹275 cr ₹241 cr 7 4 -4.75%
StockShares tradedShares PriceValue
₹ cr
New position
HDFC Bank Limited 3,000,000 entered — 213
Alkem Laboratories Limited 223,414 entered — 115
Lenskart Solutions Limited 1,080,000 entered — 74.0
Motilal Oswal Financial Services Limited 740,809 entered — 73.6
Mahindra Manulife Liquid Fund -Direct Plan -Growth 269,447 entered — 50.0
InterGlobe Aviation Limited 60,000 entered — 29.9
Shriram Finance Limited 240,000 entered — 23.6
Added to
Divi's Laboratories Limited 84,000 +26.4% -1.9% 78.1
P N Gadgil Jewellers Limited 998,747 +99.7% +1.1% 58.9
Sun TV Network Limited 883,945 +89.4% +29.8% 53.5
Eternal Limited 938,872 +69.2% -2.5% 30.0
Jindal Saw Ltd 900,000 +21.8% -10.3% 25.0
Manappuram Finance Limited 715,803 +31.0% -7.1% 22.6
Kajaria Ceramics Limited 48,959 +8.4% -0.8% 6.1
Hatsun Agro Product Limited 4,861 +4.0% -7.7% 0.5
Trimmed
Neuland Laboratories Limited 38,010 -28.5% -7.2% 81.2
Multi Commodity Exchange of India Limited 145,000 -13.2% -2.9% 47.9
Adani Enterprises Limited 150,000 -17.3% +1.6% 43.6
Gokaldas Exports Limited 513,487 -79.4% -11.9% 35.3
APL Apollo Tubes Limited 128,609 -14.9% -1.5% 28.2
Oswal Pumps Limited 179,582 -24.4% -8.7% 4.8
Sold out of
Mahindra & Mahindra Limited 250,000 exited — 82.1
LTM Limited 102,604 exited — 46.6
Tega Industries Limited 182,913 exited — 29.0
Vedanta Oil and Gas Ltd 1,800,000 exited — 7.0
Not equityPrevious filingThis filingChange
Cash, repo and TREPS ₹0 cr ₹0 cr +₹0 cr

The list above is stocks and fund units. Treasury bills, repo and money-market lines roll over every month by design — they are not decisions, so they are totalled here rather than listed as activity.

A ₹10,000 monthly SIP over five years

InvestedValueGainXIRR
₹600,000 ₹878,861 ₹278,861 15.26%

XIRR, not CAGR — a SIP's money arrives over sixty months, so each instalment has been invested for a different length of time.

Not investment advice. MF Analyser is not a SEBI-registered Investment Adviser or Research Analyst. Every figure is computed from AMFI's published NAV history and the portfolio the AMC filed with AMFI; none of it is a recommendation to buy, hold or sell. Past returns do not predict future ones. Generated 12 Nov 2026.